CA
AMLX icon

CoreCap Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

CoreCap Advisors’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$262 Buy
+9
New +$239 ﹤0.01% 2911

Other funds holding AMLX

VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CoreCap Advisors's AMLX Position: Q3 2026 in Review

CoreCap Advisors opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 9 shares worth $262. The stake represents ﹤0.01% of the portfolio and ranks #2911 among its holdings.

6 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • CoreCap Advisors held 9 shares of Amylyx Pharmaceuticals worth $262 as of Q3 2026.
  • Amylyx Pharmaceuticals was a new CoreCap Advisors position in Q3 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2911 holding.
  • 6 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.